CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $275,000 | -12.4% | 517,806 | +800.7% | 0.04% | 0.0% |
| Q4 2019 | $314,000 | +307.8% | 57,488 | +265.2% | 0.04% | +270.0% |
| Q3 2019 | $77,000 | -40.3% | 15,742 | -7.9% | 0.01% | +42.9% |
| Q3 2018 | $129,000 | -81.7% | 17,100 | -87.7% | 0.01% | -80.0% |
| Q2 2018 | $704,000 | +49.2% | 139,500 | +109.8% | 0.04% | +20.7% |
| Q4 2017 | $472,000 | -34.5% | 66,500 | -34.0% | 0.03% | -40.8% |
| Q3 2017 | $721,000 | +94.9% | 100,800 | +71.4% | 0.05% | +104.2% |
| Q2 2017 | $370,000 | – | 58,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |